QVIDTVM Management LLC
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 11, 2025), QVIDTVM Management LLC reported 8 stock positions worth $99.8 million. Its top holding was Solventum (SOLV) at 39.0% of the portfolio, followed by Bio-Rad Laboratories-A (BIO, 30.5%) and Coty Class A (COTY, 7.5%). Compared with Q1 2025, it added to 1 and reduced 4. The biggest buy was Ermenegildo Zegna (ZGN, shares +3%) and the biggest sale Rentokil Initial PLC-SP ADR (RTO, shares −66%).
- Most Recent 13F
- Q2 2026
- Location
- THE WOODLANDS, TX
- CIK
- 0001912226
- Portfolio Value
- $99.8M (Q2 2025)
- SEC Filing
- 0001912226-25-000004 ↗ filed Aug 11, 2025
Holdings Value
Holdings 8 stocks · $99.8M
| SOLV Solventum Corp. | 39.00% | 513,389 | $38.9M | Reduce -0.1% |
| BIO Bio-Rad Laboratories-A | 30.47% | 126,080 | $30.4M | Reduce -0.1% |
| COTY Coty Inc. Class A | 7.47% | 1,605,020 | $7.5M | No change |
| XRAY Dentsply Sirona Inc. | 7.38% | 463,866 | $7.4M | No change |
| RTO Rentokil Initial PLC-SP ADR | 5.33% | 221,621 | $5.3M | Reduce -66.3% |
| BRC INC-A | 4.33% | 3,301,681 | $4.3M | No change |
| ZGN Ermenegildo Zegna NV | 3.69% | 431,095 | $3.7M | Add +2.6% |
| WAB Wabtec Corp. | 2.33% | 11,104 | $2.3M | Reduce -20.7% |
Portfolio Sells Q1 2025 → Q2 2025
Portfolio Buys Q1 2025 → Q2 2025
| ZGN Ermenegildo Zegna NV | Add +2.6% | 3.69% | +0.94 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $76.6M | BIO, NBIS, AMRZ, ORCL, SOLV |
| Q1 2026 | 14 | $81.4M | BIO, SOLV, AMRZ, NBIS, ORCL |
| Q4 2025 | 13 | $88.4M | BIO, SOLV, AMRZ, XRAY, ZGN |
| Q3 2025 | 8 | $92.9M | SOLV, BIO, COTY, XRAY, BRC INC-A |
| Q2 2025 | 8 | $99.8M | SOLV, BIO, COTY, XRAY, RTO |
| Q1 2025 | 8 | $113.1M | SOLV, BIO, RTO, COTY, XRAY |
| Q4 2024 | 8 | $124.2M | BIO, SOLV, RTO, BRC INC-A, XRAY |
| Q3 2024 | 8 | $142.9M | BIO, SOLV, WAB, RTO, XRAY |
| Q2 2024 | 7 | $125.0M | BIO, RTO, SOLV, WAB, BRC INC-A |
| Q1 2024 | 10 | $124.2M | BIO, RTO, WAB, BRC INC-A, XRAY |